Home > PS Ratio > BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION

BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION
PS (Price/Sales) Ratio

The Current P/S Ratio of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION is 3.71.

Share Price ₹22.8Feb 12,2025
Market Cap ₹98.3 Cr
Sales-TTM₹26.5 CrTTM-Standalone Results
Price/Sales3.71xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION
Please provide your vote to see the results

Definition & Calculation of PS (Price/Sales) ratio of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION is calculated as :

Current Market Cap [ ₹98.3 Cr] as on Feb 12,2025

(/) Sales [ ₹26.5 Cr] based on TTM-Standalone Results

(=) P/S Ratio [ 3.71x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION , the investors are currently willing to pay '3.71 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION !

The chart below summarizes the trend in P/S Ratio of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION over the last five years.

Historical PS (Price/Sales) ratio chart of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION


PS Ratio Performance Analysis for BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION

- BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION 's latest p/e ratio is 3.71x.

- BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION 's p/e ratio for fiscal years ending Mar2023 to Mar2019 averaged 1.36x.

- BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION 's operated at median p/e ratio of 1.55x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION 's p/e ratio peaked in Mar2021 at 2.3x.

- BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION 's p/e ratio hit its five-year low in Mar2020 of 0.38x.


How does BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION 26.53.7198.3
SUN PHARMACEUTICAL INDUSTRIES LTD51,602.57.87406,363.0
CIPLA LTD26,981.24.34117,088.0
DR REDDYS LABORATORIES LTD31,229.33.25101,458.0
ZYDUS LIFESCIENCES LTD22,247.44.2394,002.4
DIVIS LABORATORIES LTD9,078.017.45158,396.0
MANKIND PHARMA LTD11,641.08.5899,899.7
TORRENT PHARMACEUTICALS LTD11,302.09.17103,668.0
LUPIN LTD22,001.64.2092,432.8
AUROBINDO PHARMA LTD30,921.82.1566,513.4
ABBOTT INDIA LTD6,243.29.7961,133.1

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 2.15x
Max industry PS 17.45x
Median industry PS 4.34x
Average industry PS 6.80x



You may also like the below Video Courses